The Braes High School pupil flew home from the US alongside mum Lisa on Saturday following her latest trip to New York where she’s been receiving doses of the bivalent vaccine.
The 14-year-old last travelled Stateside to be treated for high-risk neuroblastoma in February.
Neuroblastoma is a rare type of cancerous tumour that almost always affects children and develops from nerve cells in the fetus called neuroblasts.
Usually, as a fetus matures and after birth, the neuroblasts develop normally but can become cancerous, causing neuroblastoma.
Just before the end of 2020, Ashlee got the green light for the third bivalent instalment – approval that seemed a long way off in October when her white blood cell count was too low for her to receive the vaccine.
Her most recent journey to New York for treatment was once again met with joy by family and friends online via the Ashlee’s Neuroblastoma Appeal Facebook page.
Posting on Saturday, mum Lisa said: “Heading home from a week in New York where Ashlee received her fifth neuroblastoma bivalent vaccine and had her bone marrow biopsies taken too.
“Delighted we have been able to make these trips during Covid and of course it wouldn’t be possible at all without the generous support from you all, for which we will be eternally grateful.
“Ashlee is keeping well and continues to make us proud with everything she deals with that we wish no child should ever have to.”